Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced that its Board of Directors (the “Board”) has ...

Integer Holdings (ITGR) launches a strategic review, weighing a sale/merger or standalone path; plus Q1 FY26 results beat on ...

First quarter results in line with February outlook ~~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales ...

Medical technology company Integer Holdings (NYSE:ITGR) will be reporting results this Thursday morning. Here’s what to ...

Integer (NYSE:ITGR) reported first-quarter 2026 results that management said were in line with the outlook it provided in ...

Integer Holdings has begun a strategic review to consider a sale, merger, business combination, or continuing its standalone plan, following activist investor engagement and stronger-than-expected Q1 ...

Integer Holdings Corp ITGR reported better-than-expected first-quarter financial results on Thursday. Integer Holdings ...

Q1 2026 earnings call recap: updated guidance, EP forecast reset, margins, and strategic review highlights—read the key takeaways.

There is no deadline for the review and no assurance it will result in a transaction. Integer separately lowered its outlook for 2026, citing headwinds with three of its products.

This disposition represented 15.85% of Thomas' direct common stockholdings at the time of the transaction. The transaction was executed via direct ownership; no indirect entities or derivative ...